These results indicated the possibility that in EGFR-mutated NSCLC, the immune escape in the oncogenic activation of the EGFR pathway is mainly mediated by the upregulation of PD-L1 through EGFR activation. Here, CD274 is linked to non-small cell lung carcinoma.